Prothea Technologies
Prothea Technologies is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
About Prothea Technologies
Based in the United Kingdom, Prothea Technologies is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Prothea Technologies develops medical technology that enables lung cancer biopsy and treatment to be performed in a single hospital visit by combining diagnostic sampling with therapy, aiming to reduce time-to-treat and improve patient outcomes. The company is validating its approach through clinical studies such as the Precision Lung trial (ISRCTN15093468).
Explore Prothea Technologies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.